{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:30:30Z","timestamp":1781620230532,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T00:00:00Z","timestamp":1086220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00384-004-0595-3","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T16:39:32Z","timestamp":1086194372000},"page":"603-606","source":"Crossref","is-referenced-by-count":5,"title":["Infliximab as a therapy for non-Crohn?s enterocutaneous fistulae"],"prefix":"10.1007","volume":"19","author":[{"given":"Ravindra S.","family":"Date","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwar Jit Singh","family":"Panesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Neilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,6,3]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/PL00012349","volume":"23","author":"Dudrick","year":"1999","unstructured":"Dudrick SJ, Maharaj AR, McKelvey AA (1999) Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 23:570?576","journal-title":"World J Surg"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan SR, et al (1999) Infliximab for the treatment of fistulas in patients with Crohn?s disease. N Engl J Med 340:1398?1405","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","volume":"117","author":"Rutgeerts","year":"1999","unstructured":"Rutgeerts P, D?Haens G, Targan S, et al (1999) Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (Infliximab) to maintain remission in Crohn?s disease. Gastroenterology 117:761?769","journal-title":"Gastroenterology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJH, et al (1997) A short term study of chimeric monoclonal antibody cA2 to tumour necrosis factor ? for Crohn?s disease. N Engl J Med 337:1029?1035","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"XI","DOI":"10.1016\/S0039-6109(05)70494-1","volume":"76","author":"Meguid","year":"1996","unstructured":"Meguid MM, Campos ACL (1996) Preface: surgical management of gastrointestinal fistulas. Surg Clin North Am 76:XI","journal-title":"Surg Clin North Am"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"iv21","DOI":"10.1136\/gut.49.suppl_4.iv21","volume":"49","author":"Gonz\u00e1lez-Pinto","year":"2001","unstructured":"Gonz\u00e1lez-Pinto I, Moreno Gonz\u00e1lez E (2001) Optimising the treatment of upper gastrointestinal fistulae. Gut 49:iv21?iv28","journal-title":"Gut"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2168.2001.01659.x","volume":"88","author":"Li-Ling","year":"2001","unstructured":"Li-Ling J, Irving M (2001) Somatostatin and Octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 88:190?199","journal-title":"Br J Surg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2007-1012896","volume":"21","author":"Marone","year":"1989","unstructured":"Marone G, Santoro LM, Torre V (1989) Successful endoscopic treatment of GI tract fistulas with a fast hardening amino acid solution. Endoscopy 21:47?49","journal-title":"Endoscopy"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/gyno.2000.6092","volume":"80","author":"Alvarez","year":"2001","unstructured":"Alvarez AA, Maxwell GL, Rodriguez GC (2001) Vacuum- assisted closure for cutaneous gastrointestinal fistula management. Gynaecol Oncol 80:413?416","journal-title":"Gynaecol Oncol"},{"key":"CR10","first-page":"619","volume":"47","author":"McDermott","year":"2001","unstructured":"McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol 47:619?635","journal-title":"Cell Mol Biol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00005176-200109001-00004","volume":"33","author":"Baldassano","year":"2001","unstructured":"Baldassano RN (2001) Surpassing conventional therapies: the role of biologic therapy. J Pediatr Gastroenterol Nutr 33:S19?S26","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1345\/aph.1C039","volume":"37","author":"Nahar","year":"2003","unstructured":"Nahar IK (2003) Infliximab treatment of rheumatoid arthritis and Crohn?s disease. Ann Pharmacother 37:1256?1265","journal-title":"Ann Pharmacother"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002281-200107000-00001","volume":"13","author":"Braun","year":"2001","unstructured":"Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E (2001) New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 13:245?249","journal-title":"Curr Opin Rheumatol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.7326\/0003-4819-135-1-200107030-00009","volume":"135","author":"Anonymous","year":"2001","unstructured":"Anonymous (2001) Summaries for patients. A new anti-inflammatory therapy (Infliximab) for complicated sarcoidosis. Ann Intern Med 135:S20","journal-title":"Ann Intern Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","volume":"135","author":"Yee","year":"2001","unstructured":"Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with Infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27?31","journal-title":"Ann Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"Sfikakis","year":"2001","unstructured":"Sfikakis PP (2001) Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of Infliximab on sight-threatening panuveitis in Bechet?s disease. Lancet 358:295?296","journal-title":"Lancet"},{"key":"CR17","first-page":"930","volume":"137","author":"Tan","year":"2001","unstructured":"Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG (2001) Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn?s disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 137:930?933","journal-title":"Arch Dermatol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","volume":"357","author":"Chaudhari","year":"2001","unstructured":"Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB (2001) Efficacy and safety of Infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357:1842?1847","journal-title":"Lancet"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-004-0595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-004-0595-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-004-0595-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:05:17Z","timestamp":1559059517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-004-0595-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,3]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1007\/s00384-004-0595-3","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,3]]}}}